JENA SEC filings, in plain English
Everything JENA ACQUISITION Corp II has filed with the SEC that we hold — 39 filings, newest first, 37 with a plain-English summary of what changed and why it matters. Every row links to the primary document on EDGAR, so you can check the source rather than trust us.
The feed
live EDGAR captureNew filings appear here within minutes of hitting EDGAR; summaries follow once the pipeline has read them.
What changed: Quarterly report (Form 10-Q) for the period ended June 30, 2026. Trust value per share increased from $10.24 to $10.42 due to $4.18M in interest earned; accumulated deficit grew to ($13.9M); cash burn $846K; NYSE non-compliance for <300 public shareholders received plan acceptance with cure until October 1, 2027; no definitive agreement reached with any target. Why it matters: Trust now at $10.42/share — above $10.00 floor — providing a small buffer for redemptions. Sponsor's ability to fund operations is management's basis for going concern, but cash outside trust is only $67K. The NYSE listing risk adds deadline pressure to find a deal before May 30, 2027. No deal progress reported.
What changed vs 2026-05-15trust $237.5M → $239.6M +1%going concern APPEAREDtrust account, going-concern doubt, combination deadline +22 moved · 3 with no prior record of ours
- Trust account
- $237.5M$239.6M
- Going-concern doubt
- not statedstated
- Combination deadline
- 2027-05-30 · unchanged
- Mandate language
- we are focusing our search on identifying a prospective targ… · unchanged
- Redeemable shares
- 23.0M · unchanged
SpacBrain reads this as $2,103,913 was added to the trust between the two filings.
The clause …“assets 252,235 1,065,070 Prepaid insurance, non-current — 59,657 Investments held in Trust Account 239,633,441 235,449,992 Total Assets $ 239,885,676 $ 236,574,719 Liabilities, Class A Ordinary Shares Subject to Possible Redemption,”…
SpacBrain reads this as the substantial-doubt sentence is in this filing and not in the previous one.
The clause …“does not complete a Business Combination within the Combination Period raises substantial doubt about the Company’s ability to continue as a going concern for a period of time within one year from the date of the accompanying unaudited”…
The clause …“of the Public Shares if the Company is unable to complete the initial Business Combination by May 30, 2027 (24 months from the closing of the Initial Public Offering) or by such earlier liquidation date as the Company’s board of”…
The clause …“were 225,000 Class A Ordinary Shares issued and outstanding, excluding the 23,000,000 Class A Ordinary Shares subject to possible redemption. Class B Ordinary Shares The Company is authorized to issue a total of 50,000,000 Class B”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
What changed: 10-Q (Quarterly Report) for Jena Acquisition Corporation II for the quarter ended March 31, 2026. Trust account value increased to $237,529,528 ($10.33 per share) from $235,449,992 ($10.24 per share) due to interest earned. No definitive agreement for a business combination has been entered into as of March 31, 2026. On March 11, 2026, the Company engaged Santander and Kobre Capital as placement agents for a PIPE in connection with a proposed initial Business Combination with a target. On April 1, 2026 (subsequent event), the Company received a NYSE notice for non-compliance with minimum 300 public shareholders, requiring a compliance plan within 45 days. Formation, general, and administrative costs increased to $983,306 for Q1 2026, reflecting due diligence and M&A expenses. Net income of $1,096,230 was reported for the quarter. Why it matters: The PIPE engagement signals that JENA has identified a target and is moving toward a definitive agreement, but the NYSE listing deficiency adds uncertainty. Trust per share is growing slowly. The high expenses suggest active deal pursuit, but the deadline remains May 30, 2027. The NYSE notice could impact trading if not resolved.
What changed vs 2025-11-14trust $233.2M → $237.5M +2%trust account, mandate language, combination deadline +11 moved · 3 with no prior record of ours
- Trust account
- $233.2M$237.5M
- Mandate language
- not previously extractedwe are focusing our search on identifying a prospective targ…
- Combination deadline
- 2027-05-30 · unchanged
- Redeemable shares
- 23.0M · unchanged
SpacBrain reads this as $4,349,740 was added to the trust between the two filings.
The clause …“900,207 1,065,070 Prepaid insurance, non-current 23,864 59,657 Investments held in Trust Account 237,529,528 235,449,992 Total Assets $ 238,453,599 $ 236,574,719 Liabilities, Class A Ordinary Shares Subject to Possible Redemption,”…
The clause …“of the Public Shares if the Company is unable to complete the initial Business Combination by May 30, 2027 (24 months from the closing of the Initial Public Offering) or by such earlier liquidation date as the Company’s board of”…
The clause …“were 225,000 Class A Ordinary Shares issued and outstanding, excluding the 23,000,000 Class A Ordinary Shares subject to possible redemption. Class B Ordinary Shares The Company is authorized to issue a total of 50,000,000 Class B”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
What changed: This document IS a Form 8-K Current Report filed pursuant to Item 3.01, reporting receipt of a New York Stock Exchange listing deficiency notice, accompanied by Press Release Exhibit 99.1. According to the April 1, 2026 notice from NYSE Regulation staff, cited in the Form 8-K and reiterated in the April 3, 2026 press release issued by CEO Richard N. Massey, the company fell out of compliance with Listing Rule Section 802.01A/802.01B because it does not currently maintain a minimum of 300 public stockholders on a continuous basis. As permitted under exchange rules, the company will submit a business plan within 45 days demonstrating how it expects to regain compliance within 18 months. The press release explicitly states that returning to compliance will involve completing a de-SPAC transaction, and confirms that provided NYSE Regulation approves the plan, securities will continue trading on the NYSE under their existing ticker symbols (JENA, JENA.U, JENA.R) during the cure period without immediate delisting action. Why it matters: Outside the listing mechanics, the April 3 press release outlines organizational and strategic context: the Cayman Islands blank-check vehicle intends to capitalize on the historical business expertise of co-founder and Chairman William P. Foley, II, while directors W. Dabbs Cavin, Dexter Fowler, and Tim Hsia serve on the board. General Counsel and Corporate Secretary Michael L. Gravelle executed the filing. The exchange warning materially tightens the practical runway available to meet the stated 2027-05-30 redemption deadline, as the 18-month cure period forces rapid target selection, definitive agreement execution, and shareholder vote completion ahead of liquidation. The filing also records a corporate name correction from 'JENA ACQUISITION CORPORARTION II' to the current spelling effective March 12, 2025. Together, these disclosures highlight sponsor continuity but underscore heightened execution risk, potential public shareholder base erosion, and compressed decision-making timelines as the SPAC races to avoid both delisting and expiration.
What changed: Annual Report (Form 10-K) for the fiscal year ended December 31, 2025, filed by JENA Acquisition Corp II, a blank check company (SPAC) searching for a business combination. This is the first 10-K since the IPO (completed May 30, 2025). No business combination target selected; no extension sought. Trust account value grew from $230 million to $235.45 million with interest, resulting in a redemption price of approximately $10.23 per public share (up from $10.00). Net loss of $1.84 million for the period from inception (Feb 24, 2025) through Dec 31, 2025. Sponsor indemnification provisions remain in place. No change in deadline (May 30, 2027). Why it matters: Provides the first audited financial statements post-IPO, confirming trust per-share value above $10.00, the remaining deadline, and the absence of a definitive acquisition agreement. Investors can assess trust accretion, sponsor costs (advisory fee payable $6.9M, deferred underwriting $6.9M), and working capital ($1.04M). The filing also details management's prior SPAC track record and the risk of liquidation if no deal by May 30, 2027.
What changed: Schedule 13G/A (Amendment to a Statement of Beneficial Ownership). The filing identifies three affiliated reporting persons—Bank of Montreal, BANK OF MONTREAL HOLDING INC., and BMO NESBITT BURNS INC.—submitting an updated ownership declaration on 2026-02-12 under record number 0000927971-26-000038. The excerpt provides no share quantities, percentage thresholds, transaction dates, or acquisition purposes. Why it matters: This amendment monitors institutional capital allocation by major banking affiliates during JENA’s SEARCH period, which concludes at the published redemption deadline of 2027-05-30. Because the text discloses neither volume nor intent, it does not interact with the cash-per-share distribution mechanics tied to the $10 trust metric, does not prompt extension proposals, does not advance merger negotiations or due diligence, and does not indicate shifts in sponsor fiduciary behavior. No claims regarding commercial operations, valuation drivers, competitive positioning, legal exposure, or executive appointments are present; the only disclosed information originates from the named financial entities self-reporting their security positions to the Commission.
What changed: A routine compliance exhibit — an amended Schedule 13G beneficial ownership report filed by Bank of Montreal, Bank of Montreal Holding Inc., and BMO Nesbitt Burns Inc. The excerpt notes an update to a prior disclosure but provides no quantified data on share acquisitions, aggregate holdings, voting power allocations, or exemption basis modifications. Consequently, the precise mechanical shift in ownership position remains undisclosed within the provided text. Why it matters: Investors monitoring JENA ACQUISITION Corp II’s May 30, 2027 deadline, trust distribution mechanics, extension protocols, deal progression, or sponsor oversight will find no operative language addressing those parameters. The filing does not signal redemption elections, blockholder coordination, target announcement timelines, or charter amendments. Furthermore, the document contains no attributed assertions regarding customer concentration, revenue streams, addressable market sizing, strategic roadmaps, proprietary technology, partnership arrangements, pending litigation, or executive personnel changes. Because the excerpt advances zero verifiable claims or numeric thresholds, and every factual placeholder defaults to the filers’ administrative categorization alone, the submission reflects standard regulatory housekeeping without independent catalyst weight.
What changed: A Schedule 13G/A filing reporting beneficial ownership pursuant to Section 13(d) of the Securities Exchange Act of 1934. Barclays PLC identifies itself as the reporting holder of the registrant’s shares. The submitted text provides no share quantities, ownership percentages, transaction dates, or comparative data from earlier filings to show what changed. Why it matters: The filing does not disclose any updates to JENA’s trust account composition or per-share value, its business combination deadline (2027-05-30), extension voting procedures, shareholder redemption elections, or sponsor conduct. It contains no claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel attributed to the company, its sponsors, management, or other parties.
What changed: Quarterly report (Form 10-Q) for the quarterly period ended September 30, 2025, filed on November 14, 2025, by Jena Acquisition Corporation II, a blank-check SPAC that completed its IPO on May 30, 2025. Trust account grew to $233,179,788 ($10.14 per share) from the initial $230,000,000 ($10.00 per share) due to interest income. No definitive business combination agreement has been entered into; the company is still searching. No extension of the Combination Period (deadline May 30, 2027) has been proposed. Working capital of $1,127,460 is sufficient for at least one year. No new Working Capital Loans. Advisory fee payable of $6.9M and deferred underwriting fee of $6.9M remain contingent on a deal. Why it matters: This is the company's first quarterly report since its IPO, providing baseline financials. The trust value per share ($10.14) exceeds the redemption price, offering a modest buffer for shareholders. The absence of a target or extension confirms the company is early in its search period. Sponsor conduct remains standard; no related-party transactions beyond the administrative services agreement. The filing contains no new risk factors or litigation.
What changed vs 2025-08-13trust $230.8M → $233.2M +1%trust account, combination deadline, redeemable shares1 moved · 2 with no prior record of ours
- Trust account
- $230.8M$233.2M
- Combination deadline
- not previously extracted2027-05-30
- Redeemable shares
- 23.0M · unchanged
SpacBrain reads this as $2,418,248 was added to the trust between the two filings.
The clause …“current assets 1,257,125 Prepaid insurance, non-current 95,450 Investments held in Trust Account 233,179,788 Total Assets $ 234,532,363 Liabilities, Class A Ordinary Shares Subject to Possible Redemption, and Shareholders’ Deficit”…
The clause …“and (y) the distribution of the Trust Account, as described below. We have until May 30, 2027 (24 months from the closing of the Initial Public Offering), or until such earlier liquidation date as our Board may approve or such”…
The clause …“were 225,000 Class A Ordinary Shares issued and outstanding, excluding the 23,000,000 Class A Ordinary Shares subject to possible redemption. 14 JENA ACQUISITION CORPORATION II NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
What changed: Schedule 13G, a routine compliance exhibit and regulatory beneficial ownership report disclosing that Barclays PLC holds equity securities in JENA. Barclays PLC is identified as the reporting holder. The provided excerpt contains no share quantity, acquisition date, purchase price, percentage owned, or statement of purpose, and therefore introduces no updated parameters regarding redemption thresholds, trust fund preservation, extension votes, target identification progress, or sponsor conduct. Why it matters: Institutional investors frequently file these disclosures when crossing ownership reporting triggers, but without disclosed block sizes, pricing, or strategic intent, the filing alone does not indicate shifts in capital commitment, deal pacing, or governance posture relative to the firm’s search timeline. Assertions regarding Barclays PLC’s position are derived exclusively from the holder designation within the filing itself.
What changed: A routine compliance exhibit (Joint Filing Agreement, Exhibit A) attached to a Schedule 13G/A beneficial ownership report. The document reports no updates to redemption deadlines, trust valuation, extension schedules, merger deal progress, or sponsor conduct. It also contains no substantive claims about customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel. The filing simply records that Linden Capital L.P., Linden GP LLC, Linden Advisors LP, and Siu Min Wong agreed to file a single Schedule 13G/A on behalf of all four parties pursuant to Rule 13d-1(k), referencing an underlying statement dated November 11, 2025 and a historical power of attorney dated June 10, 2019. Why it matters: Because it lacks operational, financial, or corporate action disclosures, this exhibit does not advance or delay the SPAC’s search phase, modify shareholder redemption mechanics, or alter the May 30, 2027 termination date. Investors tracking capital call windows, trust interest accruals, or target announcement deadlines should disregard this attachment for timeline purposes and instead consult the main Schedule 13G/A summary for actual ownership percentages and any basis-of-ownership amendments.
What changed: Quarterly report (Form 10-Q) for a blank-check SPAC in its searching phase, its first 10-Q since the IPO closed on May 30, 2025. First financial statements post-IPO: trust funded at $230 million ($10.03 per share), $6.9M advisory fee accrued (contingent on deal), $1.19M working cash. No target identified, no substantive discussions. Sponsor transferred founder shares to directors; sponsor loan fully repaid. Why it matters: Establishes baseline trust value ($10.03/sh) and 24-month deadline (May 2027). Highlights non-cash advisory liability and limited sponsor indemnification capacity. Confirms the SPAC is still searching, with no deal progress.
What changed: Schedule 13G beneficial ownership report. The filing discloses that Barclays PLC holds a beneficial ownership interest in JENA Acquisition Corp II. The excerpt provides no share quantity, purchase price, or investment purpose, so there is no update to the SPAC’s trust value, redemption deadline, extension status, or sponsor conduct. Why it matters: A Schedule 13G typically signals institutional capital allocation at or above the five percent threshold during the SEARCHING phase, but Barclays PLC attributed no operational claims, customer metrics, revenue projections, technology roadmap details, partnership terms, litigation matters, or personnel changes to this submission. Without further amendments or accompanying proxies, this compliance filing does not materially alter the entity’s trajectory or timeline.
What changed: Schedule 13G — beneficial ownership report. The filing identifies Bank of Montreal, Bank of Montreal Holding Inc., and BMO Nesbitt Burns Inc. as reporting their beneficial ownership positions in Jena Acquisition Corp II as of the 2025-07-31 filing date. The provided excerpt omits share quantities, percentage thresholds, acquisition or disposition dates, and transaction pricing. Why it matters: This is a routine institutional ownership disclosure that does not alter Jena’s SEARCHING status, affect trust distribution mechanics, impact the 2027-05-30 redemption deadline, signal extension approvals, indicate target negotiation progress, or reflect sponsor governance actions. The document contains no statements regarding customers, revenue, market size, strategic direction, technology, partnerships, litigation, or executive appointments. No individual or entity attributed any operational or financial claims within the text, leaving no material data points for redemption modeling or merger diligence at this time.
What changed: a Schedule 13G joint filing agreement for beneficial ownership reporting under Rule 13d-1(k). The filing does not modify JENA ACQUISITION Corp II’s redemption deadline, trust account value per share, extension mechanics, target search status, or sponsor conduct. As executed on July 25, 2025, and filed on 2025-07-28 under SEC docket 0000950170-25-098960, it simply records that Linden Capital L.P., Linden GP LLC, Linden Advisors LP, and Siu Min Min Wong agree to submit future amendments to their Schedule 13G statements on a joint basis. Saul Ahn is designated as the authorized signatory for the corporate entities and as attorney-in-fact for Siu Min Min Wong under a Power of Attorney dated June 10, 2019. No changes to capital structure, voting thresholds, or acquisition timelines are disclosed. Why it matters: Beyond confirming a routine aggregation of existing shareholder interests to satisfy Exchange Act reporting obligations, the document contains no substantive business, financial, or operational disclosures. It makes no claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel. A cross-reference notes a prior 2019 filing (June 19, 2019) regarding holdings in Haymaker Acquisition Corp II, but offers no valuation data, target pipeline indicators, or SPAC-specific covenants. For investors monitoring redemption windows or trust movements, the filing provides zero new terms, revised calendars, or sponsor behavior updates; its utility is strictly limited to verifying that the named affiliates act collectively for regulatory disclosure purposes.
What changed: A routine compliance exhibit and press release attached to an 8-K current report. According to the July 16, 2025 press release included as Exhibit 99.1, holders of units issued in the initial public offering may elect to separately trade the Class A ordinary shares and share rights within those units, commencing July 21, 2025. Each unit comprises one Class A ordinary share, par value $0.0001 per share, and one right to receive one-twentieth (1/20) of one Class A ordinary share upon the consummation of the company’s initial business combination. Separated shares will trade on the New York Stock Exchange under the symbol "JENA," separated rights under "JENA.R," and unseparated units will continue under "JENA.U." Holders must direct their brokers to contact transfer agent Continental Stock Transfer & Trust Company to execute the separation. The filing contains zero updates regarding the May 30, 2027 redemption deadline, trust account mechanics, extension procedures, target deal progress, or sponsor conduct. Why it matters: Decoupling the equity and derivative components establishes independent trading channels, improving liquidity and allowing shareholders to price or hedge the fractional share rights separate from the base stock prior to a merger announcement. This administrative step does not modify the contractual triggers for cash redemptions, alter the timeline for trust fund payouts, or accelerate/decelerate the merger process. Regarding non-mechanical substance, the filing reconfirms the registrant is a Cayman Islands exempted blank check company organized to effect a merger, share exchange, asset acquisition, or similar business combination. The press release attributes the company's strategic posture to its principals, stating management intends to capitalize on its leadership's capabilities and "initially focus its search on identifying a prospective target business that can benefit from [co-founder and Chairman] William P. Foley, II’s and [co-founder and Chief Executive Officer] Richard N. Massey’s historical areas of business expertise." The document makes no assertions regarding customers, revenue, market size, technology, partnerships, or active litigation.
What changed: A Current Report on Form 8-K and an attached Audited Balance Sheet, filed by JENA ACQUISITION Corp II on June 5, 2025, reporting the consummation of its Initial Public Offering on May 30, 2025. The Company's filings state that on May 30, 2025, it closed its IPO of 23,000,000 Units at $10.00 per Unit, generating $230,000,000 in gross proceeds, after the underwriters fully exercised their 3,000,000-unit over-allotment option. Concurrently, the Sponsor, Jena Acquisition Sponsor LLC II, purchased 225,000 Private Placement Units for $2,250,000. The Company reports placing $230,000,000 into a trust account at Continental Stock Transfer & Trust Company. According to the filing, the Company has a Completion Window of 24 months from the IPO closing to complete a business combination, setting the liquidation deadline at May 30, 2027. The filing discloses that the Sponsor, officers, and directors have agreed via letter agreement to waive redemption rights for their founder and private placement shares, forfeit liquidating distributions from the trust on those shares if the Completion Window expires, and vote their founder and private placement shares in favor of the initial business combination. Transaction costs are listed as $7,688,532 ($250,000 cash underwriting fee, $6,900,000 deferred underwriting fee, $538,532 other offering costs), with an additional advisory fee of $6,900,000 (3% of gross proceeds) owed to the underwriter upon a business combination. Why it matters: These disclosures establish the baseline trust value, fix the shareholder redemption price mechanics at $10.00 per public share as initially anticipated, and lock the sponsor's equity alignment ahead of the target search phase. The heavy deferred compensation obligations—specifically a $6,900,000 deferred underwriting fee and a separate $6,900,000 advisory fee—create a structural hurdle for the management team, tying their compensation strictly to deal success rather than time elapsed. The audited balance sheet confirms the Company holds $1,751,508 in operating cash and $15,800 in prepaid expenses against $14,164,485 in liabilities, resulting in a reported shareholders' deficit of $(12,397,177) due to the accounting treatment of the redeemable public shares. Furthermore, the Company explicitly states as of May 30, 2025, that it has not selected any business combination target and has engaged in no substantive discussions with any target, confirming the blank check status. Chief Financial Officer Amanda G. Sturgeon signed the report on June 5, 2025.
What changed: Routine compliance exhibit: A Joint Filing Agreement (Exhibit 99.1) accompanying a Schedule 13D. This document is a routine compliance exhibit confirming a co-reporting arrangement. Bearing on redemption deadlines, trust value, extensions, deal progress, or sponsor conduct: there are no changes. Jena Acquisition Sponsor LLC II and William P. Foley, II mutually represent eligibility to jointly file a Schedule 13D for Class A ordinary shares, $0.0001 par value, of Jena Acquisition Corp. as of June 5, 2025, and assign joint responsibility for timely filing, completeness, and accuracy. Michael L. Gravelle executed the agreement as Attorney-in-Fact under a power of attorney dated May 30, 2025 (referenced as Exhibit 20.5 to a Form 4 filed May 30, 2025). Regarding other substance: the document contains zero claims about customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel. It holds no entries for a redemption calendar but substantiates standard SEC reporting coordination. Why it matters: For investors tracking SPAC mechanics, this filing confirms administrative alignment for regulatory disclosure but carries zero operational impact on the SEARCHING status, the 2027-05-30 deadline, or trust valuation. Its only substantive effect is defining shared liability for Schedule 13D accuracy under the referenced May 30, 2025 delegation. Investors should treat this as background administrative paperwork and await the primary Schedule 13D body for actual position metrics or strategic developments.
What changed: This document IS an insider ownership report (SEC Form 3) filed by director Timothy Kang Hsia for JENA ACQUISITION Corp II. According to the filing dated 2025-06-02 and registered under accession number 0001213900-25-049742, the reporting person submitted 'No non-derivative transactions or holdings reported,' meaning there have been zero changes to direct equity positions, option exercises, or derivative contracts for the named director. As disclosed by the filer, this lack of transactional activity leaves the SPAC’s redemption mechanics, trust account distribution schedule, extension referendum procedures, and target acquisition pipeline entirely unaffected by this submission. Why it matters: As stated by the document, the maintenance of the existing ownership architecture preserves investor exposure to the $10 trust value per share and the 2027-05-30 business combination deadline without introducing dilution events or altering sponsor fiduciary signaling ahead of any potential extension vote. Because the issuer’s submission contains no claims regarding customer acquisitions, revenue runrates, total addressable market sizing, proprietary technology development, strategic partnerships, or active litigation, the filing operates solely as a regulatory compliance artifact. Investors monitoring deal progress and sponsor conduct should note that while the recorded $10.00 trust metric and fixed deadline remain operationally intact, the absence of reported equity shifts provides no new data on management’s long-term capital commitment or conviction trajectory relative to the announced search-phase timeline.
What changed: SEC Form 4 insider ownership report for JENA ACQUISITION Corp II. Regarding sponsor conduct, the filing states that on 2025-05-30, reporting persons JENA ACQUISITION SPONSOR LLC II and FOLEY WILLIAM P II purchased 225,000 shares at $10 in open-market transactions. Deal progress remains unchanged at SEARCHING status. The filing does not modify the 2027-05-30 redemption deadline, propose any trust account extension, or reference adjustments to trust value per share. Why it matters: The record documents insider accumulation without accompanying commentary on customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel; therefore, any strategic interpretation is sourced entirely from the transaction log filed by the named insiders. All quantities—the 225,000 shares acquired, the $10 per-share execution price, and the transaction date of 2025-05-30—are taken verbatim from the submission. Because the disclosure lacks forward-looking assertions or corporate actions triggering redemption windows or fund terminations, it does not cross the material threshold for immediate portfolio rebalancing, though it provides a baseline for monitoring subsequent sponsor activity.
What changed: 8-K Current Report reporting the consummation of the initial public offering (IPO) of Jena Acquisition Corporation II, a blank check company (SPAC), including the exercise of the underwriters' over-allotment option in full. The Company closed its IPO of 23,000,000 units (20,000,000 firm plus 3,000,000 over-allotment) at $10.00 per unit, generating $230,000,000 in gross proceeds, all of which were deposited into the trust account. The trust per-share value is $10.00. The deadline to complete a business combination is 24 months from closing, i.e., May 30, 2027. Simultaneously, the Company sold 225,000 private placement units to the sponsor for $2,250,000. The board of directors was appointed (W. Dabbs Cavin, Dexter Fowler, Tim Hsia, plus William P. Foley II and Richard N. Massey). Standard SPAC agreements were entered into (underwriting, trust, rights, registration, private placement, letter agreement, indemnity, administrative services). The amended and restated memorandum and articles of association became effective. Why it matters: This filing establishes the foundational trust account value ($10.00 per share) and the 24-month deadline (May 30, 2027) for the business combination. It also sets lock-up periods: founder shares (Class B) are locked up until one year after the business combination (or earlier if price >= $12.00 for 20/30 days after 150 days); private placement units are locked up for 30 days after the business combination. The sponsor's private placement provides additional working capital. The management team, led by William P. Foley II and Richard N. Massey, indicates a focus on businesses that can benefit from their historical areas of expertise. Investors should track the trust value, deadline, and any future extension votes or deal announcements.
What changed: Initial public offering prospectus (424B4) for JENA Acquisition Corporation II, a blank check company (SPAC) searching for a business combination. No prior prospectus exists; this is the IPO prospectus establishing the offering terms: 20,000,000 units at $10.00 per unit, each unit consisting of one Class A ordinary share and one right (1/20 of a Class A share). Trust account of $200 million ($10.00 per share). Deadline to complete a business combination is 24 months from closing (anticipated May 30, 2025, so deadline May 30, 2027). Sponsor purchased 225,000 private placement units at $10.00 each. Public shareholders have redemption rights upon a business combination. No target has been identified. Management team led by William P. Foley II and Richard N. Massey with extensive prior SPAC experience. Why it matters: This filing sets the baseline trust value ($10.00 per share), redemption mechanics, and deadline. It details the sponsor's nominal cost ($0.004 per founder share), creating a significant dilution risk and potential conflict of interest. It also outlines the structure of rights, lock-up provisions, and the sponsor's indemnification obligations. Investors use this to understand the SPAC's terms before trading begins.
What changed: FORM 3 — a routine insider ownership compliance report. This filing states there are no non-derivative transactions or holdings changes for reporting persons JENA ACQUISITION SPONSOR LLC II and FOLEY WILLIAM P II, both documented as 10% owners. Bearing on the mechanics of redemptions, trust value, extensions, and deal progress: the submission neither moves the SEARCH-phase timeline, adjusts the stated trust value of $10, rewrites the 2027-05-30 deadline, triggers an extension vote, nor announces a business combination target. It merely logs static equity positions. Why it matters: The document contains no additional claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel. By confirming zero portfolio movement by the sponsor and lead director, it preserves the existing cash-to-share ratio and leaves the redemption trigger date undisturbed for shareholders. As reported in the filing, all figures ($10, 10%, 2027-05-30) remain unchanged, requiring no computational adjustment and signaling no shift in sponsor capital deployment behavior ahead of the mid-2027 window.
What changed: A Form 3 initial statement of beneficial ownership (insider ownership report) filed under SEC rules by director William Dexter Fowler. The filing explicitly states there are 'No non-derivative transactions or holdings reported.' Consequently, there are no updates to the SPAC’s redemption deadline of 2027-05-30, no alterations to trust account allocation or per-share valuation, and no developments regarding business combination negotiations, extension votes, or sponsor conduct adjustments. Why it matters: This routine compliance exhibit confirms the director’s Section 16(a) reporting obligation is active while documenting zero insider equity positions at the time of submission. For investors tracking redemption windows, trust preservation, or sponsor alignment, the report introduces no mechanical changes, dilution risk, or governance shifts. The document contains no claims regarding target industries, revenue projections, partnership strategies, litigation exposure, or personnel changes beyond the stated director title and the reported absence of holdings.
What changed: SEC Form 3, an initial statement of beneficial ownership of securities (routine compliance exhibit). Filed 2025-05-28 by director Cavin William Dabbs, the filing asserts 'No non-derivative transactions or holdings reported.' This records zero shift in insider equity exposure, provides no leverage data for redemptions, signals nothing regarding trust preservation or extension mechanics, and indicates no change in deal progression dynamics. Why it matters: Insider ownership baselines establish pre-deal alignment; the filing's explicit zero-reporting leaves the director's capital footprint unchanged, offering no forward-looking indicator of execution urgency or shareholder advocacy. The text contains no attributions to customers, revenue targets, market sizing, strategic initiatives, technology pipelines, partnership formations, litigation matters, or personnel changes. As a result, the submission does not compress or extend the 2027-05-30 termination window, nor does it recalculate per-share trust expectations. It functions as a static governance checkpoint that clarifies the absence of near-term insider positioning shifts during the search phase.
What changed: A routine compliance exhibit — SEC Form 3 (Initial Statement of Beneficial Ownership) — disclosing initial equity or derivative holdings for an insider of JENA ACQUISITION Corp II. Filed on 2025-05-28 under accessions identifier [0001213900-25-048424], General Counsel & Corporate Secretary Michael L. Gravelle self-reported zero non-derivative transactions and zero open holdings in the issuer. There are no alterations to insider share positions, no adjustments to sponsor or officer voting power, and no mechanical effect on the documented redemption framework (trust/share $10, deadline 2027-05-30) or the active SEARCHING classification. Beyond the reporter’s identity, title, filing timestamp, and accession number, the document contains no assertions regarding customer contracts, revenue streams, addressable markets, operating strategy, proprietary technology, commercial partnerships, pending or threatened litigation, or executive hiring or departures. Why it matters: Investors tracking JENA’s conversion mechanics and sponsor conduct receive a verified baseline showing that a principal corporate officer has not acquired or disposed of securities that could precede a business combination announcement, influence proxy contest dynamics, or alter public float thresholds. Because the self-report confirms complete inactivity, the filing exerts no pressure on the trust account balance, imposes no revision risk to the May 30, 2027 redemption horizon, and signals no deviation from the ongoing target-sourcing mandate. It satisfies statutory initial-ownership disclosure requirements while leaving all extension rights, sponsorship fee structures, and liquidation timelines functionally unchanged.
What changed: Routine compliance exhibit: Form 8-A for Registration of Certain Classes of Securities Pursuant to Section 12(b) of the Securities Exchange Act of 1934. The filing registers three security classes for New York Stock Exchange listing: Units, Class A ordinary shares, and Rights. Each Unit consists of one Class A ordinary share and one right; each right entitles the holder to one-twentieth (1/20) of one Class A ordinary share. Class A ordinary shares carry a par value of $0.0001. No adjustments to redemption windows, trust account valuation mechanics, extension voting thresholds, or target acquisition progress were disclosed. Why it matters: Chief Executive Officer Richard N. Massey executed this registration on May 28, 2025, confirming exchange listing eligibility by incorporating by reference the capital structure detailed in the Registrant’s S-1 prospectus originally filed May 12, 2025. Because the document contains no amendments to the redemption calendar, trust distribution formulas, or business combination deadlines, it does not shift the search trajectory or alter shareholder exit mechanics. The filing maintains regulatory alignment while leaving operational and financial parameters unchanged, which is typical for a searching-stage SPAC navigating post-IPO listing compliance without advancing deal activity.
What changed: A routine compliance exhibit: a Form 3 initial statement of beneficial ownership. According to the filing text, 'No non-derivative transactions or holdings reported.' There is no change to insider equity, sponsor conduct, or any mechanic governing redemptions, trust maintenance, or extensions. JENA ACQUISITION Corp II retains its SEARCHING designation, the documented $10 trust per share, and the 2027-05-30 deadline remain untouched by insider activity. Why it matters: Attested to by the filer and SEC system record, the report confirms that director, CEO, and 10% owner Richard N. Massey holds no reportable securities and executed zero transactions as of the 2025-05-28 filing date. The document contains no claims about customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel beyond his corporate titles and ownership percentage. For investors tracking redemption deadlines, trust value, extensions, deal progress, and sponsor conduct, this signals no impending deal progress, anchor commitment, or extension maneuvering from leadership, providing a clean baseline for trust accounting and proxy timing without introducing sudden insider selling pressure near the 2027-05-30 horizon.
What changed: Schedule 3 initial statement of beneficial ownership filed under Securities Exchange Act reporting rules. Per the filing, reporting person Amanda Sturgeon, CFO and Treasurer of JENA Acquisition Corp II, disclosed "No non-derivative transactions or holdings reported." Accordingly, there is no update to the issuer’s capital structure, sponsor equity composition, redemption deadline (2027-05-30), per-share trust value ($10), extension provisions, or target search progress. Why it matters: Investors tracking SPAC mechanics see a confirmed flat equity position held by the CFO, which does not alter the company’s operating cash runway, shareholder redemption threshold dynamics, or business combination termination timeline. As reported by the filer, the absence of transactions or disclosed holdings provides no signal regarding management’s near-term liquidity requirements or acquisition confidence ahead of the mid-May 2027 cutoff. The submission contains no factual claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or additional personnel movements; investors must monitor subsequent S-4 registrations, proxy statements, and press disclosures to evaluate whether a target selection or extension vote actually occurs.
What changed: A Rule 461 procedural request for acceleration of effectiveness submitted to the SEC Division of Corporation Finance concerning JENA Acquisition Corporation II’s Registration Statement on Form S-1 (filed May 12, 2025, as amended; File No. 333-287198). Nothing alters the SPAC’s mechanics. There are no adjustments to redemption deadlines, trust account valuations, extension approvals, target acquisition progress, or sponsor behavior. The submission contains no claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel. General Counsel and Corporate Secretary Michael L. Gravelle requests that the Registration Statement become effective at 4:30 p.m. Eastern Time on May 28, 2025, or as soon thereafter practicable. All dates and identifiers—May 12, 2025; May 28, 2025; 4:30 p.m.; File No. 333-287198—appear exactly as filed. No operational, financial, or governance assertions are attributed to the sponsor or management. Why it matters: For investors monitoring capital raise execution, this filing signals that the sponsor is prioritizing immediate market timing over deferred pricing or structural concessions. Seeking acceleration on a Rule 461 basis indicates readiness to close the secondary offering the moment SEC comments are cleared, preserving the existing share structure and avoiding additional regulatory delays that could trigger automatic trust protections or alter investor liquidity windows. Because the text contains zero substantive disclosures, it does not modify the redemption calendar, adjust trust mechanics, impose extensions, or reflect sponsor conduct requiring scrutiny. This remains a standard administrative step awaiting final pricing.
What changed: SEC correspondence letter from prospective underwriter to the Corporation Finance Division requesting acceleration of the Form S-1 registration statement effective date. Santander US Capital Markets LLC formally requested accelerating the S-1 effective date to 4:30 p.m. Eastern Time on May 28, 2025. The underwriter confirmed distribution of approximately 1,000 copies of the Preliminary Prospectus dated May 16, 2025, and attested to compliance with the 48-hour restriction in Rule 15c2-8(b). The filing does not modify the stated redemption deadline, trust account mechanics, extension voting procedures, or any pending business combination timeline. Why it matters: The acceleration advances the registration process, a procedural step that typically precedes a registered capital raise used to fund a target acquisition or sustain search-phase operations. The document contains no substantive claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel. Every referenced figure and date originates solely from the underwriter’s submission and aligns with the company’s existing S-1 cycle. Investors tracking redemption windows or trust valuations will find no immediate schedule or accounting shifts, but the procedural advancement warrants monitoring for a subsequent target announcement or pricing event that would deploy the newly effective registration.
What changed: A SEC Division of Corporation Finance comment letter response detailing the Company’s written answers to staff observations on Amendment No. 1 to its Registration Statement on Form S-1. In accordance with the requested reporting sequence: (1) Document identity: This is a regulatory correspondence submitted on May 16, 2025, responding to a May 15, 2025 staff comment letter regarding an S-1 initially submitted on May 12, 2025. (2) Redemption/deal/trust mechanics: The filing reports zero adjustments to the redemption calendar, trust distribution mechanics, extension provisions, or target search status. The only structural adjustments involve pre-combination corporate setup: the Company acknowledged that the sponsor transferred 10,000 founder shares to each independent director at the original per share purchase price and agreed to reflect that transfer on the cover page per Item 1602(a)(3) of Regulation S-K. The Company also reconciled a drafting discrepancy by replacing Exhibit 10.8, confirming the administrative services agreement pays the sponsor $5,000 a month (correcting a previously disclosed intent to reimburse $2,500 a month). (3) Other substance: The correspondence contains no statements regarding customer pipelines, revenue models, market sizing, proprietary technology, commercial partnerships, litigation exposure, or executive compensation beyond the signatory attribution. All disclosures are sourced directly from the Company’s written replies prepared by Chief Executive Officer Richard N. Massey and coordinated through counsel Stuart Neuhauser and David E. Fleming. Why it matters: This filing confirms the S-1 registration remains under active SEC staff review, with the Commission enforcing strict parity between narrative prospectus disclosures and filed exhibit terms. Aligning the administrative reimbursement to $5,000 a month establishes a transparent, contractually binding baseline for ongoing sponsor operating expenses that will impact net trust proceeds at combination. Listing the 10,000 founder share grants per independent director on the cover page improves pre-vote transparency regarding insider equity concentration and potential governance dynamics ahead of shareholder redemption decisions. Because the amendments address only disclosure placement and a single fee-rate correction, they neither accelerate nor delay the contractual 2027-05-30 liquidation deadline, nor do they alter shareholder redemption rights or trust payout structures. The filing is non-material to capital allocation decisions but indicates routine, staff-driven registration pacing without operational or strategic deviations.
What changed: Amendment No. 1 to Form S-1 registration statement / preliminary prospectus for Jena Acquisition Corporation II's $200,000,000 SPAC IPO of 20,000,000 units at $10.00 per unit, together with the form of underwriting agreement, the form of administrative services agreement, and the independent auditor's consent. This is the first amendment to the S-1, filed 2025-05-16. The items filed with this amendment include the form of underwriting agreement with Santander US Capital Markets LLC, the form of administrative services agreement with the sponsor, and the consent of Withum Smith+Brown, PC. The prospectus still states that no business combination target has been selected and no substantive discussions have occurred. There is no business combination agreement, no extension proposal, and no redemption-related item in this filing. Why it matters: For a searching SPAC, this filing establishes the baseline IPO terms that will drive future trust value and timing: $200.0 million will be deposited in trust at $10.00 per unit, or $230.0 million if the over-allotment option is exercised in full; the completion window is 24 months from closing of the offering; the sponsor paid $25,000 for 5,750,000 founder shares at approximately $0.004 per share; the sponsor will buy 225,000 private placement units for $2,250,000; the underwriter receives $0.30 per unit deferred underwriting compensation plus a 3% advisory fee; and the sponsor affiliate will be paid $2,500 per month for administrative services. It also discloses that 10,000 founder shares were transferred to each independent director nominee. No target has been identified, so no deal progress or redemption deadline change is reported.
What changed: SEC Division of Corporation Finance comment letter regarding a Form S-1 registration statement. First, this document is an SEC Division of Corporation Finance comment letter addressing inconsistencies in the issuer’s Form S-1 registration statement filed May 12, 2025. Second, regarding SPAC mechanics, the staff notes the sponsor transferred 10,000 founder shares to each independent director at the original per share purchase price and requires this detail on the cover page. It flags a discrepancy in the proposed administrative cost reimbursement: the registration statement discloses $2,500 a month, while Exhibit 10.8 describes the administrative services agreement sum as $5,000 a month, and requests revision to address the conflict or provide an explanation. The company’s search status, trust composition, and deadline remain untouched by this correspondence. Third, regarding other substance, the filing contains no claims about customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel; all directives and observations originate solely from the Division of Corporation Finance, not from company executives or public statements. No figures are calculated or approximated; all amounts match the registered proposal and contractual exhibit verbatim. Why it matters: Disclosure conflicts over sponsor equity allocations and recurring administrative fees typically delay S-1 effectiveness or requested acceleration under Rules 460 and 461, keeping capital in trust until the SEC clears the amendments. Until resolution, Jena Acquisition Corporation II cannot consummate a business combination, which maintains shareholder redemption rights and defers any vote on target valuation or sponsor track record. Correcting these disclosures ensures that future investors receive unambiguous data on promoter compensation and operational costs when evaluating redemption thresholds and merger terms.
What changed: Registration statement on Form S-1 for an initial public offering of 20,000,000 units (with an over-allotment option for an additional 3,000,000 units), each unit consisting of one Class A ordinary share and one right to receive one-twentieth of a Class A ordinary share upon a business combination. The issuer is a newly formed blank-check company searching for a target. The Company is filing its initial S-1 registration statement, which represents its first public disclosure. The document establishes the terms of the IPO: $200 million in trust ($10 per unit), a 24-month deadline from closing to complete a business combination (or May 2027, assuming May 2025 closing), a 15% redemption cap if seeking shareholder approval of a business combination, sponsor founder shares purchased at $0.004 per share, and sponsor purchase of 225,000 private placement units at $10 each. Why it matters: This document sets the fundamental terms for a $200 million SPAC IPO. All sponsors and officers agree not to redeem their securities. The deadline is 24 months. The dilution disclosure shows that, under a maximum-redemption scenario, public shareholders would incur 109.50% dilution. The SPAC has extensive experience drawing on the track record of co-founders William P. Foley II and Richard N. Massey, including multiple prior SPACs. Despite being a new SPAC, the detailed disclosure in this S-1 provides investors a baseline for tracking future amendments, trust account balances, and extension votes.
What changed: A SEC Division of Corporation Finance comment response letter (CORRESP) filed by Jena Acquisition Corporation II on May 12, 2025, responding to staff review of its Draft Registration Statement on Form S-1. SEC staff comments (received May 1, 2025) prompted the Company to amend its S-1 as follows regarding mechanics and sponsor conduct: (1) Staff requested disclosure of any limitations on extensions, including the number of times permitted and consequences to the sponsor for failing to extend time to consummate a business combination; the Company acknowledged and added this to page 12 under Summary/Initial Business Combination per Item 1602(b)(4) of Regulation S-K. (2) Staff noted prior disclosure that the sponsor lacks substantial ties to non-U.S. persons and requested revision clarifying whether any sponsor members hold substantial ties to non-U.S. persons; the Company revised page 66 of Risk Factors. (3) Staff queried how the Company can state it intends to use 'substantially all of the funds held in the trust account, including any amounts representing interest earned' given that funds are escrowed until business combination completion; the Company revised page 98 under Liquidity and Capital Resources. (4) Staff required disclosure per Item 404(a) of Regulation S-K of an agreement to pay a sponsor affiliate $5,000 a month for accounting, bookkeeping, office space, IT support, research, professional, secretarial, and administrative services; the Company added this to page 157 under Certain Relationships and Related Transactions. CEO Richard N. Massey transmitted the responses on May 12, 2025. The document contains no claims regarding customers, revenue, market size, technology, partnerships, litigation, or strategic initiatives beyond these regulatory disclosures. Why it matters: The amendments finalize pre-effectiveness terms that directly govern the SPAC’s 2027-05-30 search timeline and shareholder redemption calculus. Explicit extension limitation disclosures clarify deadline flexibility and sponsor penalty exposure, while the mandated $5,000 monthly affiliate payment establishes a recurring operational cost that reduces net trust proceeds available at closing. The trust account interest usage clarification addresses liquidity mechanics that dictate actual cash outflows upon business combination execution and informs redemption floor expectations. These compliance-driven revisions remove regulatory ambiguity ahead of proxy distribution and anchor the capital structure assumptions investors will apply during the redemption vote.
What changed: SEC Division of Corporation Finance staff comment letter regarding Jena Acquisition Corporation II’s draft Registration Statement on Form S-1. The SEC Division of Corporation Finance staff reviewed the draft submission dated April 7, 2025 and issued four requests affecting SPAC mechanics: the staff stated the filing must disclose any limitations on extensions, including the number of allowable extensions and the consequences to the sponsor if an extension is not pursued; the staff noted the company’s disclosure that the sponsor lacks control or substantial ties to non-U.S. persons and requested revision to clarify whether any sponsor members hold such ties; the staff questioned the stated intent to use substantially all trust account funds plus interest despite escrow conditions pending an initial business combination; and the staff directed inclusion of a related-party agreement to pay a sponsor affiliate $5,000 monthly for administrative and professional services. Why it matters: These comments define the legal boundaries for shareholder redemption windows and trust capital deployment. Clarifying extension parameters and sponsor failure consequences determines how long capital remains at risk before liquidation triggers. Resolving the trust-versus-escrow funding mechanic explains whether post-combination valuations depend on third-party debt or existing cash reserves. The mandated $5,000 monthly sponsor affiliate payment discloses recurring operating costs associated with the SPAC shell during the extended search period, which reduces net proceeds available for target acquisition and establishes baseline related-party transactions that will require shareholder approval or valuation scrutiny.
What changed: Draft registration statement (Form S-1) for an initial public offering of a blank check company (SPAC) — JENA Acquisition Corp II, filed confidentially on April 7, 2025, seeking to raise $200 million through 20 million units at $10.00 per unit. No prior registration. This is the initial public filing detailing the IPO terms: 20,000,000 units at $10.00, each unit comprising one Class A ordinary share and one right (1/20 of a share). Sponsor purchased 5,750,000 founder shares at ~$0.004 per share and will buy 225,000 private placement units at $10.00 each. Trust account will hold $10.00 per unit. Company has 24 months from closing to complete a business combination (deadline approximately April 2027). No target has been identified. Why it matters: First public disclosure of JENA II's structure and sponsor background. Investors can evaluate the management team (William P. Foley II and Richard N. Massey) with prior SPAC experience including CF Corp, Foley Trasimene I/II, Trebia, Austerlitz I/II. Key terms include 20% founder share ownership, rights requiring 20 rights for one share, anti-dilution adjustments, and the ability to extend the deadline with shareholder approval. The nominal sponsor cost ($0.004/share) creates potential incentive conflicts. The filing is preliminary and not yet effective.
In plain English
Redemption deadlinethe last day to hand shares back for cash
Set by the filing that calls the meeting. Tender after it and the company is under no obligation to pay you the trust value.
Cash in trust / trust per sharethe cash the company is holding for each public share
Filed quarterly in the 10-Q's XBRL. It earns interest between filings, so the figure on a given day is slightly higher than the last filed one — where we show that we label it an estimate.
Accession numberthe SEC's unique id for one filing
Every figure on this page carries the accession of the filing that states it, so you can open the primary document rather than trust us.